Furthermore, although PLK1 phosphorylation was detected in Cr-HCC and p53/BRCA1 modulation in HBV-HCC, functional studies involving AURKA inhibition and PLK1 modulation are needed to demonstrate whether AURKA directly mediates these effects. This evidence concerns the gene TP53 and hepatocellular carcinoma.